Natdac
Tenofovir disoproxil · Daclatasvir · Sofosbuvir
Natdac is a hiv medication containing Tenofovir disoproxil + Daclatasvir + Sofosbuvir, available as 60mg tablets.
- Category
- Hiv · Antivirals
- Active ingredient
- Tenofovir disoproxil · Daclatasvir · Sofosbuvir
- Route
- Oral use
- Form
- Tablet
- Strengths
- 60mg
Prescription rules on Natdac vary by country.
Details
- Conditions
- Chronic hepatitis c
- Alternative Name
- Epclusa
- Therapeutic Class
- Direct-Acting Antiviral
- Pharmacological Class
- HCV Protease/Polymerase Inhibitor
- Minor Side Effects
- fatigue, headache, nausea
- Moderate Side Effects
- insomnia, dizziness, diarrhoea
- Dosage Forms
- Tablet
- Administration Route
- Oral use
- Prescription Status
- Prescription medicine
- Manufacturer
- Natco Pharma
- Onset Time
- 1–2 weeks
- Duration
- 12–24 weeks
- Storage Instructions
- Store in original packaging.
- Drug Interactions
- amiodarone, rifampicin, st. john's wort
- Age Restrictions
- For adults.